Search research articles
Contact Us
Filters
Showing results (411-420 of 563) with videos related to
Page
of 57
Sort By:
The Kaohsiung Journal of Medical Sciences
|
October 13, 2018
Did AFP-L3 save ultrasonography in community screening?
Chih-Wei Yen, Yuan-Hung Kuo, Jing-Houng Wang, et al.
Langmuir : the ACS Journal of Surfaces and Colloids
|
December 24, 2021
Highly Ordered Polymer Nanostructures via Solvent On-Film Annealing for Surface-Enhanced Raman Scattering
Kai-Jie Chang, Huan-Ru Chen, Chiang-Hung Hung, et al.
Plos One
|
March 12, 2016
Comparison of Therapeutic Response and Clinical Outcome between HCV Patients with Normal and Abnormal Alanine Transaminase Levels
Cheng-Kung Wu, Kuo-Chin Chang, Po-Lin Tseng, et al.
Cancer
|
October 5, 2006
Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma
Sheng-Nan Lu, Jing-Houng Wang, Shiann-Long Liu, et al.
Scientific Reports
|
May 10, 2019
Real-world safety and efficacy of paritaprevir/ritonavir/ombitasvir plus dasabuvir ± ribavirin in patients with hepatitis C virus genotype 1 and advanced hepatic fibrosis or compensated cirrhosis: a multicenter pooled analysis
Chun-Hsien Chen, Chien-Hung Chen, Chih-Lang Lin, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
August 26, 2019
Incidence, risk factors and impact on virological response of anemia in chronic genotype 2 hepatitis C receiving sofosbuvir plus ribavirin
Chi-Ching Chen, Shui-Yi Tung, Kuo-Liang Wei, et al.
The American Journal of Gastroenterology
|
January 7, 2010
Neither diabetes mellitus nor overweight is a risk factor for hepatocellular carcinoma in a dual HBV and HCV endemic area: community cross-sectional and case-control studies
Hung-Da Tung, Jing-Houng Wang, Po-Lin Tseng, et al.
Digestive Diseases and Sciences
|
December 16, 2015
Clinical Impact of Gadoxetic Acid-Enhanced Magnetic Resonance Imaging on Hepatoma Management: A Prospective Study
Jing-Houng Wang, Tai-Yi Chen, Hsin-You Ou, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
June 11, 2013
Efficacy and safety of pegylated interferon alfa-2b and ribavirin combination therapy versus pegylated interferon monotherapy in hemodialysis patients: a comparison of 2 sequentially treated cohorts
Po-Lin Tseng, Te-Chuan Chen, Yu-Shu Chien, et al.
Updates in Surgery
|
May 13, 2026
Sustained virological response improved survival outcomes after curative resection in patients with hepatitis C virus-related hepatocellular carcinoma in the era of direct‑acting antiviral therapy
Yi-Hao Yen, Chee-Chien Yong, Chao-Hung Hung, et al.
Page
of 57
Search research articles
Search
Showing results (411-420 of 563) with videos related to
Sort By:
Page
of 57
The Kaohsiung Journal of Medical Sciences
|
October 13, 2018
Did AFP-L3 save ultrasonography in community screening?
Chih-Wei Yen, Yuan-Hung Kuo, Jing-Houng Wang, et al.
Langmuir : the ACS Journal of Surfaces and Colloids
|
December 24, 2021
Highly Ordered Polymer Nanostructures via Solvent On-Film Annealing for Surface-Enhanced Raman Scattering
Kai-Jie Chang, Huan-Ru Chen, Chiang-Hung Hung, et al.
Plos One
|
March 12, 2016
Comparison of Therapeutic Response and Clinical Outcome between HCV Patients with Normal and Abnormal Alanine Transaminase Levels
Cheng-Kung Wu, Kuo-Chin Chang, Po-Lin Tseng, et al.
Cancer
|
October 5, 2006
Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma
Sheng-Nan Lu, Jing-Houng Wang, Shiann-Long Liu, et al.
Scientific Reports
|
May 10, 2019
Real-world safety and efficacy of paritaprevir/ritonavir/ombitasvir plus dasabuvir ± ribavirin in patients with hepatitis C virus genotype 1 and advanced hepatic fibrosis or compensated cirrhosis: a multicenter pooled analysis
Chun-Hsien Chen, Chien-Hung Chen, Chih-Lang Lin, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
August 26, 2019
Incidence, risk factors and impact on virological response of anemia in chronic genotype 2 hepatitis C receiving sofosbuvir plus ribavirin
Chi-Ching Chen, Shui-Yi Tung, Kuo-Liang Wei, et al.
The American Journal of Gastroenterology
|
January 7, 2010
Neither diabetes mellitus nor overweight is a risk factor for hepatocellular carcinoma in a dual HBV and HCV endemic area: community cross-sectional and case-control studies
Hung-Da Tung, Jing-Houng Wang, Po-Lin Tseng, et al.
Digestive Diseases and Sciences
|
December 16, 2015
Clinical Impact of Gadoxetic Acid-Enhanced Magnetic Resonance Imaging on Hepatoma Management: A Prospective Study
Jing-Houng Wang, Tai-Yi Chen, Hsin-You Ou, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
June 11, 2013
Efficacy and safety of pegylated interferon alfa-2b and ribavirin combination therapy versus pegylated interferon monotherapy in hemodialysis patients: a comparison of 2 sequentially treated cohorts
Po-Lin Tseng, Te-Chuan Chen, Yu-Shu Chien, et al.
Updates in Surgery
|
May 13, 2026
Sustained virological response improved survival outcomes after curative resection in patients with hepatitis C virus-related hepatocellular carcinoma in the era of direct‑acting antiviral therapy
Yi-Hao Yen, Chee-Chien Yong, Chao-Hung Hung, et al.
Page
of 57